VANGUARD GROUP INC - COGNITION THERAPEUTICS INC ownership

COGNITION THERAPEUTICS INC's ticker is and the CUSIP is 19243B102. A total of 37 filers reported holding COGNITION THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of COGNITION THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$989,130
-19.1%
686,896
+2.8%
0.00%
Q2 2023$1,223,218
-4.0%
668,425
+3.9%
0.00%
Q1 2023$1,273,912
+11.3%
643,390
+18.1%
0.00%
Q4 2022$1,144,267
+50.2%
544,889
+35.8%
0.00%
Q3 2022$762,000
+408.0%
401,203
+465.7%
0.00%
Q2 2022$150,000
-6.8%
70,920
+21.0%
0.00%
Q1 2022$161,000
-56.6%
58,596
+0.0%
0.00%
Q4 2021$371,00058,5790.00%
Other shareholders
COGNITION THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,038,853$2,935,9481.39%
Worth Venture Partners, LLC 508,719$732,5550.44%
AMERICAN FINANCIAL GROUP INC 205,000$2950.10%
CASTLE WEALTH MANAGEMENT LLC 43,380$62,4680.04%
CARLSON CAPITAL L P 290,000$417,6000.03%
FCA CORP /TX 51,471$74,1180.03%
PATHSTONE FAMILY OFFICE, LLC 2,205,377$3,175,7430.02%
Neumann Capital Management, LLC 33,382$48,0700.02%
Steward Financial Group LLC 40,874$580.02%
Perigon Wealth Management, LLC 223,500$321,8400.01%
View complete list of COGNITION THERAPEUTICS INC shareholders